Positive News SentimentPositive NewsNASDAQ:CALC CalciMedica (CALC) Stock Price, News & Analysis $1.72 -0.03 (-1.44%) As of 11:52 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About CalciMedica Stock (NASDAQ:CALC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CalciMedica alerts:Sign Up Key Stats Today's Range$1.62▼$1.7550-Day Range$1.74▼$5.0052-Week Range$1.62▼$36.00Volume19,620 shsAverage Volume193,002 shsMarket Capitalization$11.71 millionP/E RatioN/ADividend YieldN/APrice Target$50.00Consensus RatingHold Company Overview CalciMedica is a clinical-stage biopharmaceutical company focused on developing therapies for serious inflammatory and immune-mediated diseases. The company’s research is centered on calcium release-activated calcium (CRAC) channels, which help regulate immune-cell activation and inflammatory responses. CalciMedica’s lead investigational product is Auxora, also known as zelnecirnon or CM4620. The selective CRAC channel inhibitor has been evaluated in clinical studies for conditions including acute pancreatitis and associated acute kidney injury, as well as other diseases involving excessive inflammation. Auxora remains an investigational therapy and has not been approved for commercial use. CalciMedica was founded in 2007 and is based in La Jolla, California. The company became publicly traded on the Nasdaq under the symbol CALC following a business combination with Graybug Vision that was completed in 2023. Its clinical development activities have primarily involved studies in the United States, with potential applications for its platform being evaluated across multiple inflammatory disease areas.AI Generated. May Contain Errors. Read More CalciMedica Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreCALC MarketRank™: CalciMedica scored higher than 89% of companies evaluated by MarketBeat, and ranked 39th out of 908 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingCalciMedica has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on no strong buy ratings, 2 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialCalciMedica has a consensus price target of $50.00, representing about 2,815.5% upside from its current price of $1.72.Amount of Analyst CoverageCalciMedica has only been the subject of 4 research reports in the past 90 days.Read more about CalciMedica's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CalciMedica are expected to grow in the coming year, from ($5.25) to ($3.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CalciMedica is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CalciMedica is -0.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about CalciMedica's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.28% of the float of CalciMedica has been sold short.Short Interest Ratio / Days to CoverCalciMedica has a short interest ratio ("days to cover") of 1.13, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CalciMedica has recently decreased by 12.52%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCalciMedica does not currently pay a dividend.Dividend GrowthCalciMedica does not have a long track record of dividend growth. News and Social Media3.6 / 5News SentimentN/A News SentimentCalciMedica has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for CalciMedica this week, compared to 2 articles on an average week.Search Interest5 people have searched for CALC on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership3.6 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $199,176.00 in company stock, which represents 1.7004% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, CalciMedica insiders have bought more of their company's stock than they have sold. Specifically, they have bought $199,176.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders28.25% of the stock of CalciMedica is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsCalciMedica has minimal institutional ownership at this time.Read more about CalciMedica's insider trading history. Receive CALC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CALC Stock News HeadlinesCalciMedica consensus price target raised 400% to $38.25September 15, 2026 | msn.comCalciMedica Inc. (NASDAQ:CALC) Receives Average Recommendation of "Hold" from BrokeragesSeptember 14, 2026 | americanbankingnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 25 at 1:00 AM | Stansberry Research (Ad)CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | markets.businessinsider.comCalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | globenewswire.comCalciMedica, Inc. (CALC) Stock Major Holders - Yahoo FinanceSeptember 2, 2026 | finance.yahoo.comCalciMedica Announces 1-for-5 Reverse Stock SplitAugust 27, 2026 | rttnews.comCalciMedica Announces One-for-Five Reverse Stock SplitAugust 27, 2026 | globenewswire.comSee More Headlines CALC Stock Analysis - Frequently Asked Questions How have CALC shares performed this year? CalciMedica's stock was trading at $32.95 at the beginning of the year. Since then, CALC stock has decreased by 94.8% and is now trading at $1.7150. How were CalciMedica's earnings last quarter? CalciMedica Inc. (NASDAQ:CALC) announced its quarterly earnings data on Tuesday, August, 11th. The company reported ($0.45) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.43) by $0.98. When did CalciMedica's stock split? Shares of CalciMedica reverse split before market open on Monday, August 31st 2026.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did CalciMedica IPO? CalciMedica (CALC) raised $90 million in an initial public offering (IPO) on Friday, September 25th 2020. The company issued 5,625,000 shares at a price of $15.00-$17.00 per share. Who are CalciMedica's major shareholders? CalciMedica's top institutional investors include 180 Wealth Advisors LLC (0.53%). Insiders that own company stock include Sanderling Venture Partners Vi, Robert N Wilson, Eric W Roberts, Sudarshan Hebbar, Kenneth A Stauderman, A Rachel Leheny and Stephen Bardin. View institutional ownership trends. How do I buy shares of CalciMedica? Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CalciMedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that CalciMedica investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), AST SpaceMobile (ASTS), NIO (NIO), Bakkt (BKKT) and Castor Maritime (CTRM). Company Calendar Last Earnings8/11/2026Today9/25/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 4 weeks, CALC's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CALC CIK1534133 Webwww.calcimedica.com Phone858-952-5500FaxN/AEmployees15Year Founded2007Price Target and Rating Average Price Target for CalciMedica$50.00 High Price Target$50.00 Low Price Target$50.00 Potential Upside/Downside+2,815.5%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($6.80) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.56 million Net MarginsN/A Pretax MarginN/A Return on Equity-863.40% Return on Assets-155.24% Debt Debt-to-Equity Ratio1.67 Current Ratio5.58 Quick Ratio5.58 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($2.30) per share Price / Book-0.75Miscellaneous Outstanding Shares6,830,000Free Float4,899,000Market Cap$11.71 million OptionableNo Data Beta0.83 Social Links 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:CALC) was last updated on 9/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
